Guidance for industry : hypertension indication, drug labeling for cardiovascular outcome claims.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2008] |
| Description | 1 online resource (7 p.). |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS118691 |
| Subjects |
| Portion of title | Hypertension indication |
| Portion of title | Drug labeling for cardiovascular outcome claims |
| General note | "Labeling." |
| General note | "March 2008." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 7). |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:H 99 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |